Authors:
BENGTSSON F
HOGLUND P
BJORK H
REIS M
LUNDMARK J
ERIKSSON B
LINDSTROM E
NORDIN C
WALINDER J
Citation: F. Bengtsson et al., ROUTINE THERAPEUTIC DRUG-MONITORING (TDM) OF THE NEUROLEPTIC COMPOUNDS RISPERIDONE AND 9-OH RISPERIDONE APPLIED IN A PHARMACOKINETIC POSTMARKETING SURVEILLANCE STRATEGY, Nordic journal of psychiatry, 52, 1998, pp. 23-23
Authors:
BENGTSSON F
HOGLUND P
LIDEN A
NORDIN C
WALINDER J
Citation: F. Bengtsson et al., KINETIC POSTMARKETING SURVEILLANCE OF THE ATYPICAL ANTIDEPRESSANTS MIANSERINE AND MOCLOBEMIDE BY USING ROUTINE THERAPEUTIC DRUG-MONITORING (TDM) DATABASES, Nordic journal of psychiatry, 52, 1998, pp. 24-24
Authors:
BENGTSSON F
HOGLUND P
LUNDMARK J
NORDIN C
WALINDER J
Citation: F. Bengtsson et al., POSTMARKETING SURVEILLANCE BY A THERAPEUTIC DRUG-MONITORING (TDM) ROUTINE FOR SSRIS CLEARLY IMPROVES DOSING AND DRUG SAFETY - ON BEHALF OF THE CROPS-GROUP, Nordic journal of psychiatry, 52, 1998, pp. 25-25
Authors:
EBERHARD G
VONKNORRING AL
VONKNORRING L
RUTZ W
TRASKMANBENDZ L
WISTEDT B
ABERGWISTEDT A
WALINDER J
Citation: G. Eberhard et al., EDUCATIONAL ACTIVITIES CONCERNING DEPRESSION AND SUICIDE - COLLABORATION BETWEEN THE BALTIC STATES AND THE SWEDISH PTD COMMITTEE, Nordic journal of psychiatry, 52, 1998, pp. 35-35
Citation: L. Haglund et al., OCCUPATIONAL FUNCTIONING IN RELATION TO PSYCHIATRIC DIAGNOSES - SCHIZOPHRENIA AND MOOD DISORDERS, Nordic journal of psychiatry, 52(3), 1998, pp. 223-229
Authors:
LUNDMARK J
BENGTSSON F
NORDIN C
REIS M
WALINDER J
Citation: J. Lundmark et al., THERAPEUTIC DRUG-MONITORING OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS CITALOPRAM, PAROXETINE, AND SERTRALINE IN THE TREATMENT OF DEPRESSION IN THE ELDERLY REDUCES DRUG COSTS, Nordic journal of psychiatry, 52(2), 1998, pp. 106-107
Authors:
BENGTSSON F
HOGLUND P
LUNDMARK J
NORDIN C
WALINDER J
Citation: F. Bengtsson et al., POSTMARKETING SURVEILLANCE BY A THERAPEUTIC DRUG-MONITORING ROUTINE FOR SELECTIVE SEROTONIN REUPTAKE INHIBITORS CLEARLY IMPROVES DOSING ANDDRUG SAFETY, Nordic journal of psychiatry, 52(2), 1998, pp. 111-112
Authors:
BENGTSSON F
HOGLUND P
BJORK H
REIS M
LUNDMARK J
ERIKSSON B
LINDSTROM E
NORDIN C
WALINDER J
Citation: F. Bengtsson et al., ROUTINE THERAPEUTIC DRUG-MONITORING OF THE NEUROLEPTIC COMPOUNDS RISPERIDONE AND 9-OH-RISPERIDONE APPLIED IN A PHARMACOKINETIC POSTMARKETING SURVEILLANCE STRATEGY, Nordic journal of psychiatry, 52(2), 1998, pp. 119-120
Authors:
BENGTSSON F
HOGLUND P
LIDEN A
NORDIN C
WALINDER J
Citation: F. Bengtsson et al., KINETIC POSTMARKETING SURVEILLANCE OF THE ATYPIC ANTIDEPRESSANTS MIANSERINE AND MOCLOBEMIDE BY USING ROUTINE THERAPEUTIC DRUG-MONITORING DATABASES, Nordic journal of psychiatry, 52(2), 1998, pp. 120-121
Citation: M. Landen et al., CLINICAL CHARACTERISTICS OF A TOTAL COHORT OF FEMALE AND MALE APPLICANTS FOR SEX REASSIGNMENT - A DESCRIPTIVE STUDY, Acta psychiatrica Scandinavica, 97(3), 1998, pp. 189-194
Authors:
RUTZ W
WALINDER J
PIHLGREN H
VONKNORRING L
RIHMER Z
Citation: W. Rutz et al., LESSONS FROM THE GOTLAND STUDY ON DEPRESSION, SUICIDE AND EDUCATION -EFFECTS, SHORTCOMINGS AND CHALLENGES, International journal of methods in psychiatric research, 6, 1996, pp. 9-14
Citation: J. Walinder, MEN AS WOMEN - EXPERIENCES FROM 5 CASES AFTER ADMINISTRATIVE, HORMONAL, AND SURGICAL-TREATMENT - COMMENTS, Nordic journal of psychiatry, 50(5), 1996, pp. 401-401
Citation: J. Walinder, COMPARATIVE EFFICACY AND SAFETY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE SHORT-TERM AND MEDIUM-TERM TREATMENT OF MAJOR DEPRESSIVE-DISORDERS, Nordic journal of psychiatry, 50(1), 1996, pp. 55-59
Authors:
FALL PA
EKMAN R
GRANERUS AK
THORELL LH
WALINDER J
Citation: Pa. Fall et al., ECT IN PARKINSONS-DISEASE - CHANGES IN MOTOR SYMPTOMS, MONOAMINE METABOLITES AND NEUROPEPTIDES, Journal of neural transmission, 10(2-3), 1995, pp. 129-140
Citation: D. Jonsson et J. Walinder, COST-EFFECTIVENESS OF CLOZAPINE TREATMENT IN THERAPY-REFRACTORY SCHIZOPHRENIA, Acta psychiatrica Scandinavica, 92(3), 1995, pp. 199-201
Authors:
LUNDMARK J
WALINDER J
ALLING C
MANNICHE PM
DALGAARD L
Citation: J. Lundmark et al., THE EFFECT OF PAROXETINE ON CEREBROSPINAL-FLUID CONCENTRATIONS OF NEUROTRANSMITTER METABOLITES IN DEPRESSED-PATIENTS, European neuropsychopharmacology, 4(1), 1994, pp. 1-6
Citation: D. Jonsson et J. Walinder, THE SOCIOECONOMIC COST OF TREATMENT OF THERAPY-REFRACTORY SCHIZOPHRENIC-PATIENTS IN SWEDEN, Nordic journal of psychiatry, 48(5), 1994, pp. 311-313
Authors:
BALLDIN J
BERGGREN U
BOKSTROM K
ERIKSSON M
GOTTFRIES CG
KARLSSON I
WALINDER J
Citation: J. Balldin et al., 6-MONTH OPEN TRIAL WITH ZIMELIDINE IN ALCOHOL-DEPENDENT PATIENTS - REDUCTION IN DAYS OF ALCOHOL INTAKE, Drug and alcohol dependence, 35(3), 1994, pp. 245-248
Authors:
KRISTOFFERSON A
SOHLAKERLUND A
HALL E
BENGTSSON BO
OGENSTAD S
WALINDER J
Citation: A. Kristofferson et al., EFFECT OF ZIMELDINE AND ITS METABOLITES ON [H-3] THYMIDINE INCORPORATION IN LYMPHOCYTE-CULTURES FROM PSYCHIATRIC-PATIENTS WITH OR WITHOUT AHYPERSENSITIVITY REACTION DURING ZIMELDINE THERAPY, International clinical psychopharmacology, 9(3), 1994, pp. 179-185
Authors:
BENGTSSON BO
WIHOLM BE
MYRHED M
WALINDER J
Citation: Bo. Bengtsson et al., ADVERSE EXPERIENCES DURING TREATMENT WITH ZIMELDINE ON SPECIAL LICENSE IN SWEDEN, International clinical psychopharmacology, 9(1), 1994, pp. 55-61
Citation: Ks. Bjorksten et J. Walinder, DOES MIANSERIN INDUCE INVOLUNTARY MOVEMENTS IN BRAIN-DAMAGED PATIENTS, International clinical psychopharmacology, 8(3), 1993, pp. 203-204